PEM POCUS Series: Pediatric First-Trimester Pregnancy

PEM POCUS pediatric cardiac

Read this tutorial on the use of point of care ultrasonography (POCUS) for pediatric first-trimester pregnancy evaluation. Then test your skills on the ALiEMU course page to receive your PEM POCUS badge worth 2 hours of ALiEMU course credit.

Module Goals

  1. List the indications for performing an obstetric point-of-care ultrasound (POCUS)
  2. Identify the characteristic findings of an intrauterine pregnancy in the first-trimester
  3. Describe how to measure fetal heart rate (FHR) and methods of estimating gestational age using POCUS
  4. Identify findings concerning for ectopic pregnancy in the first-trimester of pregnancy

Case Introduction

A 17-year-old female with a past medical history of pelvic inflammatory disease, presents as a walk-in from triage with lower abdominal pain and vaginal bleeding that started this morning. She has soaked through three pads since this morning without the passage of clots. She reports mild nausea, and dizziness. She denies any fevers, chills, chest pain, shortness of breath, vomiting, or decreased appetite. She is currently sexually active with one male partner in a monogamous relationship and does not use protection. Her menstrual periods are irregular and she is unsure of her last menstrual period.

On arrival, her vital signs are:

Vital SignFinding
Temperature37 C
Heart rate94 bpm
Blood pressure98/62
Respiratory rate14
Oxygen saturation (room air)99%

Exam

The patient is in mild distress secondary to pain and is lying supine in the stretcher. She has mild tenderness in lower quadrants with some voluntary guarding. There is no evidence of abdominal distension, rebound, rigidity, or palpable masses. Bowel sounds are present. On the pelvic exam, she has some blood in the vaginal vault, but no clots. No abnormal discharge. There is mild tenderness on the bimanual exam. The cervical os is closed. There is no cervical motion tenderness.

Diagnostics and Management

She is started on IV fluids and is given PO acetaminophen. Vitals improve to HR 85, BP 105/70, RR 12, 99% on RA. Basic labs, PT/PTT/INR, type and screen, and a urine pregnancy test are sent. While waiting for the results, you are concerned about an ectopic pregnancy and decide to perform a point-of-care (POCUS) obstetric ultrasound examination.

An obstetric POCUS can be performed using both the curvilinear (transabdominal approach) and endocavitary probes (transvaginal approach). Certain anatomical structures such as the ovaries and an early pregnancy can be visualized earlier and with greater detail using an endocavitary probe due to its closer proximity to the area of interest. While earlier pregnancies may be identified by the transvaginal approach, we recommend starting with the transabdominal probe because it is less invasive. The transabdominal examination is best performed with a full bladder and the endocavitary examination is best performed with an empty bladder. Longitudinal and transverse views of the uterus should be obtained when using either the transabdominal or endocavitary probe.

ultrasound probes

Figure 1. Different probes used for first-trimester pregnancy ultrasound

transabdominal positioning

Figure 2. Positioning for transabdominal approach

  • Position the ultrasound machine to the patient’s right with the screen facing you (figure 2).

Obtaining the transverse view

  • Place the transabdominal probe with the probe marker toward the patient’s right, just above the pubic bone and identify the bladder and uterus. The fundus of the uterus may be visualized superior to the bladder if the uterus is anteverted and posterior to the bladder if retroverted.
  • Once the uterus is identified, scan through the uterus in its entirety and identify the myometrium, and endometrium.
  • An examination of the adnexa can also be attempted to identify the ovaries, potential masses, or surrounding free fluid. The ovaries typically measure 2-3 cm in diameter and appear less echogenic than the surrounding tissue.
transabdominal view transverse

Figure 3. Normal transverse view of the uterus and bladder using the transabdominal probe. Image courtesy of The Pocus Atlas and Drs. Lindsay Davis and Hannah Koplinski

Obtaining the longitudinal (sagittal) view

  • Rotate the transabdominal probe clockwise 90 degrees so that the probe marker is facing the patient’s head.
  • In this view, you should be able to identify the bladder, uterine fundus, uterine body, cervix, vaginal canal, posterior cul-de-sac, and rectum. The thin, hyperechoic line in the center of the uterus is the endometrial stripe.
  • An examination of the adnexa may also be attempted to identify the ovaries, potential masses, or surrounding free fluid (especially in the retrouterine cul de sac) by fanning slowly left and right.
transabdominal longitudinal view pregnancy

Figure 4. Normal longitudinal (sagittal) view of an anteverted uterus and bladder using the transabdominal probe. Image courtesy of The Pocus Atlas and Drs. Lindsay Davis and Hannah Koplinski

Not all institutions have access to an endocavitary probe. However, if your institution does, the transvaginal ultrasound examination can provide additional views of the uterus and surrounding structures.

  1. Position the ultrasound machine to the patient’s right with the screen facing you, similar to the transabdominal positioning.
  2. Position the patient in the dorsal lithotomy position (similar to a normal pelvic exam), drape the patient, and have a chaperone present in the room
  3. Place gel at the tip of the endocavitary probe and apply a sterile condom or cover over the endocavitary probe. Subsequently apply sterile gel to the tip of the covered probe.

endocavitary positioning

Figure 5a. Positioning of endocavitary probe in transvaginal approach using a simulation model

Endocavitary probe

Figure 5b. Indicator labeled on endocavitary probe

Obtaining the longitudinal view

  • Hold the probe with the indicator at the 12 o’ clock position (figure 5b).
  • Slowly insert the probe until the endometrial stripe is visualized
  • Tilt/fan the probe to the left and right and identify the bladder, uterine fundus, endometrial stripe, myometrium, cervix, posterior cul-de-sac, and rectum

Obtaining the transverse view

  • Rotate the probe counterclockwise so that the indicator is facing the patient’s right (9 o’ clock position).
  • Tilt/fan the probe up and down to visualize the bladder, endometrium and myometrium.
  • Obtain a view of the ovaries by looking at the adnexa (lateral and/or posterior to the uterus).

Key Point: To definitively diagnose an intrauterine pregnancy, either a yolk sac or fetal pole must be visualized within the gestation sac of the uterus.

There are many conflicting opinions about the upper limits of the discriminatory zone (B-hCG level at which an embryo is expected to be seen). In general, for a patient with a positive B-hCG with concern for an ectopic pregnancy, an ultrasound should be performed. Typically, a pregnancy should be visible by transvaginal ultrasound examination with a B-hCG of 1000-2000 mIU/mL and by transabdominal ultrasound examination at 6000-6500 mIU/mL [1, 2].

Figure 6. Double decidual sac sign in a normal intrauterine pregnancy

Figure 7. Fetal pole and yolk sac in a normal intrauterine pregnancy

In these sonographic images, there are several characteristic sonographic features of a normal first-trimester IUP. To definitively diagnose an intrauterine pregnancy, either a yolk sac or fetal pole must be visualized within the gestation sac of the uterus.

  1. Gestational sac – an intrauterine, fluid-filled (anechoic or black) structure surrounding the embryo. This is the first structure seen in pregnancy by ultrasound in the first trimester and is characterized as an anechoic circular cavity
  2. Double decidual sac sign – consists of the decidua parietalis (lining of the uterine cavity) and the decidua capsularis (lining of the gestational sac) which on ultrasound is visualized as two concentric rings surrounding an anechoic gestational sac. The presence of a double decidual sac sign is highly indicative of an early intrauterine pregnancy (figure 6) [3].
  3. Yolk sac – this is the first anatomic structure identified within the gestational sac in the first-trimester and is seen on ultrasound as a circular, thick-walled echogenic structure with an anechoic center within the gestational sac (figure 7).
  4. Fetal pole – the growing embryo appears as an echogenic thickened margin on the edge of the yolk sac (figure 7).
  5. Ensure the gestational sac is well seated within the fundus of the uterus and surrounded by at least 5 mm of myometrium on all sides.

Once the embryo is identified, a fetal heart rate (FHR) can be obtained as early as 6 weeks of gestation. The fetal heart movement may be visualized as a flicker of movement. Visualization can be performed using either the endocavitary or curvilinear probe and the M-mode function. In POCUS, we do not use Doppler as this has a theoretical risk to the fetus.

To calculate the FHR, follow the following steps:

  1. Identify the beating fetal heart.
  2. Enlarge and center: Use the zoom function on the machine to enlarge fetal heart image
  3. M-mode: Align the M-mode line over the fetal heart, record the M-mode, and freeze the image. Find the sine wave and measure either crest to crest, or trough to trough.

A normal FHR usually ranges from 110-160 beats per minute. It begins around 90–110 bpm and increases to 170 bpm by 9 weeks of estimated gestational age.

Figure 8. Fetal heart rate measurement (rate of 148 bpm) using M-mode

The most accurate time to estimate gestational age is during the first trimester. Accurate estimation of gestational age is crucial for guiding prenatal care, decision making in high-risk pregnancies, and establishing a reliable due date. This can be performed by either measuring mean sac diameter (MSD) or crown-rump length (CRL).

Measuring mean sac diameter (MSD)

The MSD is the earliest measurement that can be used to estimate gestational age. This measurement is, however, less accurate than using crown-rump length and is typically performed between 5-8 weeks of gestation using the following steps:

  1. Obtain a longitudinal view of the gestational sac
  2. Measure the height and the length of the gestational sac
  3. Rotate the probe 90 degrees to obtain a transverse view of the gestation sac
  4. Measure the width of the gestational sac
  5. Add the height, length, and width then divide by 3 to obtain the MSD

Most ultrasound machines should help you perform this calculation; however, the gestational age can be calculated manually using the following formula: [4]

Gestational Age (days) = MSD (mm) + 30

Measuring crown-rump length (CRL)

Once an embryo is present in the gestational sac, CRL can be measured. CRL is the most accurate single measurement and is typically used to estimate gestational age between 6-13 weeks of gestation [4]. This measurement can be performed using the following steps:

  1. Obtain a mid-sagittal view of the entire embryo
  2. Measure the cephalic pole to caudal rump

Most ultrasound machines should help you perform this calculation. There are also available calculators (e.g. perinatology.com CRL calculator).

Figure 9. Crown rump length measurement showing an estimated fetal age of 6 weeks and 3 days

An ectopic pregnancy is a pregnancy in which a fertilized egg implants and grows outside the uterine cavity. The most common site for an ectopic pregnancy is the ampulla of the fallopian tube. The primary goal of performing an obstetric ultrasound in a pregnant patient who presents with abdominal pain, pelvic pain, and vaginal bleeding is not to rule in an ectopic pregnancy, but rather to rule in an IUP.

Ruling in an IUP essentially rules out an ectopic pregnancy, given that the incidence of a heterotopic pregnancy – the simultaneous occurrence of an intrauterine and an ectopic pregnancy – is 1 in 30,000. The rate of heterotopic pregnancies, however, rises significantly in patients who have undergone in-vitro fertilization (IVF) to ranges from 1 in 100 to 1 in 500 pregnancies [5]. A history of pelvic inflammatory disease also increases concern for heterotopic and ectopic pregnancy.

Uterus Views

If an empty uterus is visualized on bedside ultrasound in a patient (as shown below) with a B-hCG level greater than the discriminatory zone, the next step is to examine the adnexa for sonographic signs of an ectopic pregnancy. However, the lack of a visualized IUP on POCUS in a pregnant patient is concerning for ectopic pregnancy, and it is not expected to be able to visualize the actual ectopic pregnancy.

Video 1. Coronal (transverse) view of uterus without an intrauterine pregnancy

Video 2. Sagittal (longitudinal) view of uterus without an intrauterine pregnancy

Adnexa Views

To examine the adnexa in the transabdominal view, ensure that the patient has a full bladder and identify the uterus in the sagittal and transverse views. Using the uterus as a landmark, sweep laterally and posteriorly at which point the ovaries may or may not be visualized. Use color Doppler to help distinguish the ovary (which has a vascular hilum) from surrounding structures. Sonographic signs of an ectopic pregnancy include:

1. Tubal ring sign

A thick hyperechoic ring around a hypoechoic tubal mass

Video 3. Coronal (transverse) view of uterus showing tubal ring sign

2. Ring of fire sign

A well-circumscribed hypoechoic structure surrounded by a hypervascular ring seen on color Doppler due to trophoblastic activity and neovascularization. Note that the ring of fire sign is also present in corpus luteum cysts, which are a type of functional ovarian cyst that forms after ovulation to support a possible pregnancy.

Figure 10. Ring of fire of the adnexa

Free Fluid Assessment

If there is high suspicion for an ectopic pregnancy, assess for free fluid in the pelvis and abdomen, especially in the posterior cul-de-sac (pouch of Douglas) and hepatorenal recess (Morison’s pouch). The hepatorenal view is key for detecting hemoperitoneum in the supine patient. Fluid will often collect in Morison’s pouch first. Sweep through the pelvis in both sagittal and transverse planes to look for anechoic or hypoechoic fluid. While trace fluid may be normal in patients, the presence of moderate to large amounts of free fluid, particularly if echogenic (suggesting hemoperitoneum), raises concern for ruptured ectopic pregnancy and warrants immediate intervention. Ultimately, if the bedside ultrasound is inconclusive in a patient with clinical concern for ectopic pregnancy, a radiology performed ultrasound and/or gynecology consult should be ordered urgently.

Figure 11. Free fluid collecting in the right upper quadrant hepatorenal recess (Morison’s pouch)

Uterine fibroids, also known as leiomyomas or myomas, are benign smooth muscle tumors of the uterus. On ultrasound, they typically appear as well-circumscribed, hypoechoic (relative to the myometrium) structures that can arise within the myometrium (intramural), along the outer surface of the uterus (subserosal), project into the endometrial cavity (submucosal), and can be attached by a stalk (pedunculated).

Figure 12. Uterine fibroids

A molar pregnancy, also called a hydatidiform mole, is a type of gestational trophoblastic disease that results from abnormal fertilization, leading to the growth of abnormal trophoblastic tissue rather than a normal embryo.

A complete mole, which occurs due to fertilization of an empty ovum by one (or two) sperm, typically has a “snowstorm” or “cluster of grapes” appearance. On ultrasound, the uterus may appear larger than expected for gestational age and may show a diffusely echogenic intrauterine mass with numerous cystic spaces.

Figure 13. Molar pregnancy

An ovarian cyst is a fluid-filled sac within or on the surface of the ovary. Most are benign and functional, especially in reproductive-age women, and often resolve spontaneously.

On ultrasound, simple ovarian cysts appear as a thin, smooth-walled anechoic structure. A corpus luteum cyst, which may have a “ring of fire” appearance on color Doppler, is more thick-walled in appearance. Hemorrhagic cysts tend to have mixed echogenicity with a lacy, reticular pattern.

Figure 14. Ovarian cysts

Ovarian torsion is often on the differential for female patients presenting with sudden onset lower abdominal pain. It is a gynecologic emergency where the ovary twists on its own vascular pedicle, compromising blood flow. Patients with large ovarian cysts or masses ≥5cm are at increased risk.

On ultrasound, an enlarged, edematous ovary with absent or decreased flow may suggest this diagnosis. The ovary also tends to have peripheralized follicles. A midline ovary can also be a concerning sign. Venous flow is typically lost prior to arterial flow; however, presence of flow does not rule out ovarian torsion. Lastly, a highly specific finding for ovarian torsion may be the presence of a whirlpool sign which is visualized as a targetoid, coiled structure on color Doppler.

Figure 15. Ovarian torsion with midline, edematous ovary

Integration of the obstetric POCUS into early pregnancy assessment can significantly accelerate diagnosis and initiation of treatment, particularly in urgent cases like an ectopic pregnancy. Faster timelines could translate into improved clinical outcomes and more efficient ED workflows.

Studies that helped shape the landscape for the utility of POCUS in early pregnancy in the emergency department setting include:

StudyStudy Type, Location (Time frame)N, AgesNotes
Doubilet et al., N Engl J Med. 2013 [6]Review ArticleN/AThis review establishes more stringent ultrasound criteria for diagnosing early pregnancy failure to minimize false-positive results:

  • CRL ≥7 mm without heartbeat or MSD ≥25 mm without embryo confirm a nonviable pregnancy.
  • Equivocal findings trigger serial scans and hCG monitoring to safely evaluate uncertain cases.

These guidelines are designed to protect viable pregnancies from premature or inappropriate interventions.

Thamburaj et al. Pediatr Emerg Care. 2013 [7]Retrospective case-cohort review, Single ED at Newark Beth Israel Medical Center (2007)330 Female patients aged 13-21

Bedside POCUS group (n = 244, ~74%; Radiology group (n = 86)

Time-to-scan: 82 min vs. 149 min (POCUS vs. radiology), P < 0.001

LOS: 142 min vs. 230 min (P < 0.001)

Despite similar demographics, chief complaints, diagnoses, and dispositions between groups, bedside ultrasound significantly reduced both scan time and overall ED stay.

McRae et al. CJEM. 2009 [8]Systematic review, multiple EDs including international dataN/AED-targeted ultrasound is highly specific and reliably identifies IUP. The specificity for detecting IUP exceeded 98% in most studies, and sensitivity typically above 90%.

Bedside ultrasound reduced missed ectopic diagnosis, decreased time to surgical treatment for ectopic cases, shortened ED lengths of stay in normal pregnancies, and showed greater cost-effectiveness versus formal radiology ultrasound.

Durston et al. Am J Emerg Med. 2000 [9]Retrospective cohort, single-center (1992-1998)120 patients diagnosed with ectopic pregnancyCompared 3 different ultrasound availability models over sequential time periods:

  1. Radiology-performed ultrasound only
  2. Limited ED physician-performed ultrasound availability
  3. Full ED physician-performed bedside ultrasound availability

Increasing ED ultrasound availability improved the quality of ectopic pregnancy detection.

The combined approach of initial ED physician bedside ultrasound followed by formal imaging when indicated was the most cost-effective and efficient.

Mateer et al. Acad Emerg Med. 1995 [10]Prospective cohort, single-center148 pregnant women at risk for ectopic pregnancyEmergency physicians trained in bedside transvaginal ultrasound (TVUS) demonstrated a 93% agreement rate with gynecologists in interpreting scans. Most ectopic pregnancies were identified early, allowing prompt management.

Established feasibility and high accuracy of ED physician-performed POCUS for early pregnancy evaluation, promoting wider adoption in emergency care.

Beals et al. Am J Emerg Med. 2019 [11]Systematic review, multi-center2,350 patients across 6 studiesPatients who received POCUS had a mean reduction in ED LOS of 73.8 minutes (95% CI: 49.1–98.6) compared to those who underwent comprehensive ultrasound.

All included studies reported decreased LOS with POCUS.

Table 1. Key published studies on first-trimester obstetric POCUS

Case Resolution

You use a curvilinear abdominal probe (Figure 16) and endocavitary probe (Figure 17) and visualize the following:

ring of fire ultrasound adnexa

Figure 16. Right adnexal view showing a “ring of fire” sign suggestive of an ectopic pregnancy

Figure 17. Sagittal view of uterus showing the absence of an intrauterine pregnancy

Given her initial low blood pressure and an obstetric ultrasound concerning for an ectopic pregnancy, you decide to perform a FAST exam, and you see free fluid in the hepatorenal recess.

Figure 18. Right upper quadrant abdominal view, showing free fluid in Morison’s pouch

ED Course

Serum labs show the following:

  • hCG 8400 mIU/mL
  • WBC 13.3 x 103/uL
  • Hematocrit 25.1%

The obstetrics and gynecology team is consulted for a likely ectopic pregnancy, and the patient is taken to the OR for an emergent laparotomy.

References

  1. Hamza A, Meyberg-Solomayer G, Juhasz-Böss I, et al. Diagnostic Methods of Ectopic Pregnancy and Early Pregnancy Loss: a Review of the Literature. Geburtshilfe Frauenheilkd. 2016;76(4):377-382. doi:10.1055/s-0041-110204
  2. Kadar N, DeVore G, Romero R. Discriminatory hCG zone: its use in the sonographic evaluation for ectopic pregnancy. Obstet Gynecol. 1981;58(2):156-161. PMID: 7254727
  3. Rodgers SK, Chang C, DeBardeleben JT, Horrow MM. Normal and Abnormal US Findings in Early First-Trimester Pregnancy: Review of the Society of Radiologists in Ultrasound 2012 Consensus Panel Recommendations. Radiographics. 2015;35(7):2135-2148. doi:10.1148/rg.2015150092
  4. Weissleder R, Wittenberg J, Harisinghani MG, Chen JW. Primer of Diagnostic Imaging. 5th ed. Mosby/Elsevier; 2011. ISBN: 9780323065382
  5. Habana A, Dokras A, Giraldo JL, Jones EE. Cornual heterotopic pregnancy: contemporary management options. Am J Obstet Gynecol. 2000;182(5):1264-1270. doi:10.1067/mob.2000.103620. PMID: 10819869
  6. Doubilet PM, Benson CB, Bourne T, Blaivas M. Diagnostic Criteria for Nonviable Pregnancy Early in the First Trimester. N Engl J Med. 2013;369(15):1443-1451. doi:10.1056/NEJMra1302417
  7. Thamburaj R, Sivitz A. Does the use of bedside pelvic ultrasound decrease length of stay in the emergency department? Pediatr Emerg Care. 2013;29(1):67-70. doi:10.1097/PEC.0b013e31827b53f9. PMID: 23283267
  8. McRae A, Murray H, Edmonds M. Diagnostic accuracy and clinical utility of emergency department targeted ultrasonography in the evaluation of first-trimester pelvic pain and bleeding: a systematic review. CJEM. 2009;11(4):355-364. doi:10.1017/s1481803500011416. PMID: 19594975
  9. Durston WE, Carl ML, Guerra W, Eaton A, Ackerson LM. Ultrasound availability in the evaluation of ectopic pregnancy in the ED: comparison of quality and cost-effectiveness with different approaches. Am J Emerg Med. 2000;18(4):408-417. doi:10.1053/ajem.2000.7310. PMID: 10919529
  10. Mateer JR, Aiman EJ, Brown MH, Olson DW. Ultrasonographic examination by emergency physicians of patients at risk for ectopic pregnancy. Acad Emerg Med. 1995;2(10):867-873. doi:10.1111/j.1553-2712.1995.tb03099.x. PMID: 8542485
  11. Beals T, Naraghi L, Grossestreuer A, Schafer J, Balk D, Hoffmann B. Point of care ultrasound is associated with decreased ED length of stay for symptomatic early pregnancy. Am J Emerg Med. 2019;37(6):1165-1168. doi:10.1016/j.ajem.2019.03.025. PMID: 30948256

Dump the Myths, Not the Milk: Medication and Imaging Considerations for Lactating Patients in the Emergency Department

lactation myths with medications and imaging
The challenges in lactation are often compounded by outdated beliefs held by clinicians.  Most of the medications we administer in the emergency department (ED) do not warrant any interruption in expression or feeding of breastmilk. Most imaging we perform in the ED is safe in the lactating patient and likewise does not need interruption. Let us convince you to trash the phrase, “Pump and Dump” in the ED.

Most medications commonly given in the ED are safe in lactation

Evidence suggests medication transfer through breast milk is frequently overestimated, with actual infant exposure typically minimal for most medications commonly prescribed in emergency settings [1]. The majority of medications administered in the ED are compatible with continued breastfeeding or pumping without interruption [2]. The practice of “pumping and dumping” is harmful to infants and lactating adults given the many benefits of lactation [3, 4]. It can cause irreparable disruptions in supply, increased parental burden and stress, and is not medically indicated except in very rare circumstances (chemotherapeutics for example) [3, 4]. When uncertainty exists regarding medication safety during lactation, clinicians should consult evidence-based resources such as LactMed or the LactRx app [iphone] to provide informed recommendations. A brief summary table is provided below for quick reference on some common medications.

Medication ClassSafe in LactationCautions in Lactation
Analgesia
  • Acetaminophen [5]
  • Ibuprofen [6]
  • Opioids in routine doses: Oxycodone [7], Morphine [8], Hydromorphone [9],  Fentanyl [10]
  • ⚠️ Caution in very high doses or prolonged infusions of opioids
  • Data on oxycodone shows no adverse effects attributed to oxycodone in maternal doses up to 60 mg/day (~90 MME/day) [11], which is well within the range of typical short-term ED prescribing for acute pain [12]
Sedative Hypnotics
  • Propofol [13]
  • Ketamine [14]
  • Midazolam [15]
  • Safe to feed when awake
  • ⚠️ Caution in infusions and higher doses of long-acting benzodiazepines
Paralytics
  • Succinylcholine [16]
  • Rocuronium [17]
  • Safe to feed when no longer paralyzed; likely safe to feed even on infusions
Opioid Use Disorder
  • Buprenorphine [18]
  • Methadone [19]
  • Recommended to continue feeding
Antibiotics
  • Penicillins [20]
  • Cephalosporins [20]
  • Macrolides [20]
  • Metronidazole [21]
  • Doxycycline (≤21 days) [22]
  • ⚠️ Trimethoprim-sulfamethoxazole (Avoid in premature, ill or jaundiced and those with G6PD) [23]
Anti-hypertensives
  • Labetalol [24]
  • Nifedipine [25]
  • Captopril, Enalapril, Benzapril (Lisinopril—less data) [26]
  • HCTZ [27]
  • Furosemide [28]
  • ⚠️ Diuretics may decrease milk supply if dehydrated
  • ❌ ARBs (Losartan) — No safety data and other alternatives are safe [26]
Antidepressants
  • Sertraline [29]
  • Paroxetine [30]
  • Fluoxetine [31]
  • Citalopram [32]
  • Do not stop an effective antidepressant because of lactation. Risk of depression relapse outweighs the small differences in milk transfer.
  • ⚠️ Bupropion (case reports of infant seizures without causal link) [33]
  • ❌ Doxepin (case reports of infant respiratory depression, hypotonia) [34]
Anticonvulsants
  • Carbamazepine [35]
  • Valproic acid [36]
  • Phenytoin [37]
  • Lamotrigine [38]
  • ⚠️ Levetiracetam (levels can be high, monitor for somnolence) [39]
  • ⚠️ Topiramate (case reports of infant somnolence) [40]
  • ❌ Phenobarbital (Avoid due to high infant exposure and sedation risk) [41]

Most Imaging Performed in the ED is Safe in Lactation

Radiation Exposure

Radiation exposure from diagnostic imaging we typically use in the ED (CT, x-ray) is minimal and there is no need to interrupt nursing/pumping [42].

IV contrast

Iodinated and gadolinium contrast agents are safe and do not require interruption of breastfeeding [43]. Read more in the American College of Radiology 2025 ACR Manual on Contrast Media (start at page 94).

In suspected pulmonary embolism (PE), CT pulmonary angiography (CTPA) is preferred over V/Q scan in lactating patients due to contrast safety (no breastfeeding interruption required), speed and availability, and high rates of indeterminate V/Q scans requiring subsequent CTPA [43, 44].

Exception: In the rare circumstance where contrast is contraindicated (such as anaphylaxis) and a radioactive tracer is indicated (V/Q scan with Tc-99m MAA), the radioactivity does warrant separation from both patient contact and milk for a period of time determined by the rate of decay of the specific agent [45]. Keep expressed milk stored appropriately until radioactivity has been able to decay then it’s safe to feed [46].

References (AMA Format)

  1. Nauwelaerts N, Macente J, Deferm N, Bonan RH, Huang MC, Van Neste M, et al. Generic workflow to predict medicine concentrations in human milk using physiologically-based pharmacokinetic (PBPK) modelling—a contribution from the ConcePTION project. Pharmaceutics. 2023;15(5):1469. doi:10.3390/pharmaceutics15051469
  2. Premer C, Caruso K. Safety profile of the most ordered medications for breastfeeding patients in the emergency department. Am J Emerg Med. 2024;80:1-7. doi:10.1016/j.ajem.2024.02.042
  3. Sachs HC; Committee On Drugs. The transfer of drugs and therapeutics into human breast milk: an update on selected topics. Pediatrics. 2013;132(3):e796-e809. doi:10.1542/peds.2013-1985
  4. Meek JY, Noble L; Section on Breastfeeding. Policy statement: breastfeeding and the use of human milk. Pediatrics. 2022;150(1):e2022057988. doi:10.1542/peds.2022-057988
  5. Acetaminophen. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  6. Ibuprofen. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  7. Oxycodone. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  8. Morphine. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  9. Hydromorphone. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  10. Fentanyl. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  11. FDA drug label. Food and Drug Administration; 2024-2025.
  12. Zhu W, Chernew ME, Sherry TB, Maestas N. Initial opioid prescriptions among US commercially insured patients, 2012-2017. N Engl J Med. 2019;380(11):1043-1052. doi:10.1056/NEJMsa1807069
  13. Propofol. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  14. Ketamine. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  15. Midazolam. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  16. Succinylcholine. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  17. Rocuronium. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  18. Buprenorphine. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  19. Methadone. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  20. Spencer JP, Thomas S, Trondsen Pawlowski RH. Medication safety in breastfeeding. Am Fam Physician. 2022;106(6):638-644.
  21. Metronidazole. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  22. Doxycycline. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  23. Trimethoprim-sulfamethoxazole. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  24. Labetalol. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  25. Nifedipine. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  26. Park K. Management of women with acquired cardiovascular disease from pre-conception through pregnancy and postpartum: JACC Focus Seminar 3/5. J Am Coll Cardiol. 2021.
  27. Hydrochlorothiazide. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  28. Furosemide. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  29. Sertraline. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  30. Paroxetine. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  31. Fluoxetine. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  32. Citalopram. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  33. Bupropion. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  34. Doxepin. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  35. Carbamazepine. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  36. Valproic acid. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  37. Phenytoin. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  38. Lamotrigine. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  39. Levetiracetam. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  40. Topiramate. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  41. Phenobarbital. In: Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; 2006.
  42. Naseri M, Shahsavan M, Salahshour F, et al. Effective dose for radiological procedures in an emergency department: a cross-sectional study. Radiat Prot Dosimetry. 2020;189(1):63-68. doi:10.1093/rpd/ncaa013
  43. ACR Committee on Drugs and Contrast Media. ACR Manual on Contrast Media. American College of Radiology; 2025.
  44. Falster C, Hellfritzsch M, Gaist TA, et al. Comparison of international guideline recommendations for the diagnosis of pulmonary embolism. Lancet Haematol. 2023;10(11):e922-e935. doi:10.1016/S2352-3026(23)00181-3
  45. El-Sayed Y, Phillips Heine R, Wharton KR, eds. Guidelines for Diagnostic Imaging During Pregnancy and Lactation. American College of Obstetricians and Gynecologists; 2017.
  46. Leide-Svegborn S, Ahlgren L, Johansson L, Mattsson S. Excretion of radionuclides in human breast milk after nuclear medicine examinations: biokinetic and dosimetric data and recommendations on breastfeeding interruption. Eur J Nucl Med Mol Imaging. 2016;43(5):808-821. doi:10.1007/s00259-015-3286-0
By |2026-03-24T13:23:44-07:00Mar 26, 2026|Ob/Gyn, Radiology, Tox & Medications|

SAEM Clinical Images Series: Bilateral Leg Swelling with a Uterine Twist

The patient is a 40-year-old female who presents to the Emergency Department with bilateral leg swelling. Her symptoms started six days prior and have progressively worsened. Her symptoms are associated with shortness of breath with no chest pain. The patient has taken an over-the-counter diuretic, which has helped with her symptoms. She also reports intermittent vaginal bleeding for the past two months, with a LMP that was two months prior. She is not currently on contraceptives, and does endorse unprotected intercourse over this time. The patient denies headache, blurry vision, nausea or vomiting, abdominal pain, urinary complaints, diarrhea or constipation. She has no other complaints at this time.

Vitals: BP 140/86; HR 97; R 14; T 99°F; O2 sat 99% on room air.

General: Well appearing, no acute distress.

Respiratory: Clear to auscultation.

Cardiovascular: Regular rate and rhythm, no murmur.

Abdomen: Soft, nondistended, nontender.

Extremities: Trace bilateral pitting edema. Normal range of motion, neurovascularly intact, equal pulses bilaterally.

Neurological: No focal neurological deficits.

Hgb: 9.6 (previously 13.3 two years prior)

Creatinine: Normal

BNP: 706 pg/mL

Serum -HCG: 874,342 mIU/ml

This patient has a complete molar pregnancy.

Molar pregnancy is part of a spectrum of gestational trophoblastic tumors that include benign hydatidiform moles, locally invasive moles, and choriocarcinoma. Patients classically present with painless first or early second trimester vaginal bleeding with uterine size larger than expected gestational age and excessively high β-hcg levels. Some patients develop anemia, hyperemesis gravidarum, clinical hyperthyroidism, and signs of preeclampsia including hypertension, headaches, proteinuria and edema. Acute respiratory distress can occur due to embolization of trophoblastic tissue into the pulmonary vasculature, thyrotoxicosis, or simple fluid overload. Management involves removal of molar tissue through D&C or dilation and suction evacuation. Histopathologic examination of the products of conception is the gold standard for the diagnosis of a molar pregnancy. β-hcg levels are then monitored to ensure complete resolution and to detect any signs of persistent trophoblastic disease. In some cases, adjunct chemotherapy or even hysterectomy may be needed.

Take-Home Points

  • Molar pregnancy can be diagnosed with excessively high β-hcg levels and an ultrasound that shows a classic “snowstorm” or “bunches of grapes” finding.

  • Consider gestational trophoblastic disease in any patient with signs and symptoms of preeclampsia prior to 20 weeks gestation.

  • Cavaliere A, Ermito S, Dinatale A, Pedata R. Management of molar pregnancy. J Prenat Med. 2009 Jan;3(1):15-7. PMID: 22439034; PMCID: PMC3279094.
  • Soper, John T. MD. Gestational Trophoblastic Disease: Current Evaluation and Management. Obstetrics & Gynecology 137(2):p 355-370, February 2021. | DOI: 10.1097/AOG.0000000000004240



By |2026-01-31T19:31:26-08:00Feb 6, 2026|Ob/Gyn, SAEM Clinical Images|

SAEM Clinical Images Series: A Curious Case of Abdominal Pain

The patient is a 22-year-old G0P0 female who presents to the Emergency Department with two days of left lower quadrant abdominal pain. The patient rates her pain as 10/10 in intensity, sharp in character, and states the pain radiates to her lower back. She notes similar intermittent pain over the past few months, but the pain became persistent over the past two days and has worsened. She also reports decreased appetite with nausea and vomiting. Her pain is exacerbated by movement. She began her menstrual period three days before presentation and denies being sexually active. She was previously prescribed oral contraception for treatment of menorrhagia, but discontinued it five months ago. She denies any fever, chills, chest pain, shortness of breath, urinary frequency, dysuria, vaginal discharge, bleeding, or vaginal pain.

Vitals: BP 132/84; HR 89; R 17; T 98.6°F; O2 sat 100% on room air

General: Appears uncomfortable due to pain.

Cardiovascular: Normal rate, regular rhythm.

Abdominal: Soft, non-distended, LLQ tenderness to palpation without rebound or guarding, bowel sounds present.

Genitourinary: No active bleeding or discharge, no signs of infection. No masses palpated.

WBC: 4.8

Hgb: 13.2

BMP: Normal

LFT’s: Normal

Urinalysis: Normal

Urine pregnancy test: Negative

This patient has a mature cystic teratoma (Dermoid Cyst).

Mature cystic teratomas (MCTs), also known as dermoid cysts, are benign ovarian germ cell tumors. While MCTs can occur in women of any age, they are found primarily in patients of reproductive age, with a median age of mid-30s. Patients may present asymptomatically, or with symptoms including nausea/vomiting, abdominal pain, and vaginal bleeding. Pelvic ultrasound or abdominal CT are first-line imaging studies, as well as laboratory testing to include ruling out pregnancy. In this patient with a negative UA and urine pregnancy test, abdominal CT was obtained and showed a large pelvic mass containing bony structures. Intraoperatively, the patient was found to have a large left ovarian dermoid cyst with evidence of torsion. The cyst contained multiple teeth and brown hair, and the diagnosis was confirmed with surgical pathology. Ovarian torsion is a serious complication of MCT and occurs in 3% to 21% of cases. If concomitant ovarian torsion is suspected, emergent gynecologic consultation is warranted.

Take-Home Points

  • Dermoid cysts are benign ovarian germ cell tumors that may grow large, cause significant pain, and often contain teeth and hair.

  • Ovarian torsion is an emergent potential complication of dermoid cysts and may require emergent consultation and surgical intervention.

  • Cong L, Wang S, Yeung SY, et al. Mature Cystic Teratoma: An Integrated Review. Int J Mol Sci. 2023;24(7):6141. doi: 10.3390/ijms24076141. PMID: 37047114.
  • Ahmed A, Lotfollahzadeh S. Cystic Teratoma. 2023. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. PMID: 33231995.



By |2026-01-31T19:24:41-08:00Feb 2, 2026|Ob/Gyn, SAEM Clinical Images|

SAEM Clinical Images Series: Alternative Block

A 10-year-old female with a history of constipation presented with intermittent lower abdominal pain with difficulty urinating. Pain was in the suprapubic area. The patient stated she last urinated the morning of presentation and typically urinates 1-2 times a day. She reported that it is sometimes hard to initiate urination and that she has pain at the conclusion of urination. She typically takes MiraLAX daily for constipation but ran out one week ago. She denied fever, chills, nausea or vomiting.

Constitutional: Awake, alert and in no acute distress.

HEENT: PERRLA. Moist mucus membranes.

Cardiovascular: Regular rate and rhythm. No murmur.

Pulmonary: Breath sounds normal. No increased work of breathing.

Abdominal: Abdomen soft. There is tenderness in the suprapubic area. There is no guarding or rebound.

Neurologic: Awake and alert. At neurologic baseline. No focal deficits.

UA: Trace ketones, 100 protein.

Post void residual: 430 cc.

X-ray of the abdomen is normal without obstruction or a significant stool burden. Ultrasound demonstrates a distended fluid-filled vagina.

Imperforate hymen. The opening of the vagina is typically surrounded by a thin membrane with an opening in the center, called the hymen. In the case of an imperforate hymen, the membrane does not have an opening and therefore blocks the vaginal canal. Symptoms of imperforate hymen vary. It can present early in life if normal mucous builds up and causes a bulge of the membrane. Imperforate hymen may not be diagnosed until adolescence when menstruation begins. Symptoms at that time include amenorrhea, back pain, lower abdominal pain, or difficulty with urinating or stooling. In an adolescent with imperforate hymen, physical exam may demonstrate a vaginal bulge with a bluish discoloration, caused by the accumulation of blood in the vagina (hematocolpos). This patient had urinary retention secondary to imperforate hymen and accumulation of blood in the vaginal canal that compressed the urethra. A genitourinary exam was later performed and confirmed the diagnosis. Imperforate hymen is treated with a minor surgical procedure to remove the extra tissue.

Take-Home Points

  • Imperforate hymen occurs when the hymen covers the vaginal entire vaginal opening, therefore blocking it. It may present early in life or later during adolescence.

  • Consider imperforate hymen as a differential diagnosis for female patients who present with lower abdominal or back pain, amenorrhea, or difficulty with urinating or stooling.

  • Diagnosis and management of hymenal variants. ACOG. (2019, May 23). https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/06/diagnosis-and-management-of-hymenal-variants

  • Hamouie A, Dietrich JE. Imperforate Hymen: Clinical Pearls and Implications of Management. Clin Obstet Gynecol. 2022 Dec 1;65(4):699-707. doi: 10.1097/GRF.0000000000000703. Epub 2022 Mar 11. PMID: 36260009.

By |2025-02-26T14:55:11-08:00Feb 28, 2025|Ob/Gyn, Pediatrics, SAEM Clinical Images|

SAEM Clinical Images Series: Unidentified Intrauterine Object

IUP

A 31-year-old female G3P2 presented to the emergency department with vaginal spotting for one week and worsening lower abdominal cramping. She tested positive on a home pregnancy test one day prior to presentation. On the day of presentation, she passed a small blood clot and bled through one pad. She had not yet seen an OB for this pregnancy. Her last menstrual period was one month and three days prior. The current pregnancy is undesired. She denied fevers, chills, urinary symptoms, lightheadedness, palpitations, shortness of breath, nausea, or vomiting.

Vitals: BP 95/55; HR 75; Temp 98.4°F; Resp 16; SpO2 100% on room air

Abdomen: Soft; tender to palpation in the suprapubic region, no guarding or rebound tenderness

GU: Scant blood in the vaginal canal, no clots or tissue; os closed, no adnexal tenderness, no cervical motion tenderness

bHCG: 36,966

Rh Factor: Positive

Hgb: 9.2

Ectopic pregnancy needs to be ruled out. This patient has vaginal bleeding, a positive pregnancy test, and abdominal pain. She has not established care with an OB provider and has not had a confirmed intrauterine pregnancy. Specific ultrasound findings for an ectopic pregnancy include a gestational sac with a yolk sac outside of the uterus. Findings suggestive of an ectopic pregnancy include complex adnexal masses, free fluid with debris (suggestive of rupture), and an empty gestational sac within an adnexal mass.

Yes, this is a viable intrauterine pregnancy (IUP). Confirmation can be done with transabdominal ultrasound but in very early pregnancy may require a transvaginal ultrasound. Findings needed to confirm an IUP include a gestational sac containing a yolk sac within a thickened myometrium. The hyperechoic structure seen on transabdominal and transvaginal ultrasounds for this patient is an intra-uterine device (IUD) that is in place. The risk of pregnancy with an IUD in place is <1%; according to a database of 18 million hospital deliveries, the reports of retained IUD at birth was 12 per 100,000 births. For pregnancies with an IUD in place, the rate of ectopic pregnancy is higher. There is also a higher risk of maternal infection, miscarriage, preterm premature rupture of membranes, preterm birth, and intrauterine fetal demise. For desired pregnancies, if the strings are visible, the IUD is removed as soon as possible and a single dose of azithromycin is given due to increased risk of infection during pregnancy. There is limited evidence to guide management for desired pregnancies when strings are not visible. One option is hysteroscopic removal, although this increases the risk of pregnancy loss. More than 50% of pregnancies with in situ IUDs were found to end in spontaneous abortion.

Take-Home Points

  • A definite IUP requires an intrauterine gestational sac with yolk sac and/or embryo (with or without cardiac activity).
  • Pregnancy with an IUD is extremely rare and increases the risk of ectopic pregnancy, maternal infection, miscarriage, PPROM, preterm birth, and fetal demise.
  • Management for desired pregnancies with IUDs in place when IUD strings are visible consists of early IUD removal with a single dose of prophylactic antibiotics.

  • ACOG Practice Bulletin No. 121: Long-acting reversible contraception: Implants and intrauterine devices. Obstet Gynecol. 2011 Jul;118(1):184-196. doi: 10.1097/ AOG.0b013e318227f05e. PMID: 21691183.
  • Ganer H, Levy A, Ohel I, Sheiner E. Pregnancy outcome in women with an intrauterine contraceptive device. Am J Obstet Gynecol. 2009 Oct;201(4):381.e1-5. doi: 10.1016/j.ajog.2009.06.031. Epub 2009 Aug 29. PMID: 19716537.
  • Roline, C.E., Heegaard, W.G. & Anderson, K.S. Early pregnancy with an intrauterine device in place. Crit Ultrasound J 3, 91–92 (2011). https://doi.org/10.1007/s13089-011-0068-1

By |2024-09-28T21:27:46-07:00Oct 4, 2024|Ob/Gyn, SAEM Clinical Images, Ultrasound|

SAEM Clinical Images Series: One Month of Vaginal Bleeding

heterogenous uterus

A 28-year-old female G3P2002 presented to the emergency department for one month of vaginal bleeding. The patient was seen in the emergency department one month earlier for vaginal bleeding in the first trimester of pregnancy. Her estimated gestational age was six weeks by last menstrual period. At the time her beta-hCG was 7225 mlU/mL with no intrauterine pregnancy demonstrated on transvaginal ultrasound. Three days later, the patient had declining b-hCG and transvaginal ultrasound again with no intrauterine pregnancy. The patient was discharged home with a diagnosis of miscarriage. Since discharge, she endorsed an initial slowing of vaginal bleeding but over the last two weeks bleeding had become heavier and continuous; soaking up to eight pads a day. She endorsed worsening nausea and vomiting over the past two weeks. She has been sexually active since her last encounter. She denied abdominal pain, pelvic pain, cramping, dizziness, shortness of breath, or fevers.

Vitals: BP 136/70; Pulse 96; Temp 97.8°F; Resp 16; SpO2 100%

Constitutional: No distress

Cardiovascular: Normal rate, regular rhythm, normal heart sounds

Abdomen: Soft and non-tender; Gravid uterus approximately 10 weeks

Pelvic exam: Active vaginal bleeding of dark red blood originating from the cervical os. Cervical os is closed and otherwise normal in appearance. Multiple clots are seen in the vaginal canal and posterior fornix. Vaginal canal and external genitals are normal in appearance.

Beta-HCG: 91,401 mlU/mL

Hemoglobin: 12.8 g/dL

Our patient’s case is convoluted by reporting a miscarriage the month prior, with declining beta-HCG and transvaginal ultrasounds with no intrauterine pregnancy. While her symptoms never fully resolved she endorsed that her vaginal bleeding slowed and only started getting worse after resuming intercourse.

Her physical exam of a gravid uterus of approximately 10 weeks (despite reporting a miscarriage four weeks prior), persistent vaginal bleeding, and intractable nausea and vomiting are concerning for molar pregnancy [1]. Molar pregnancies typically present as abnormal uterine bleeding in the first or second trimester and are accompanied by symptoms of hyperemesis gravida secondary to the increase in beta-hCG [2]. The two main risk factors for gestational trophoblastic disease are the extremes of maternal age and prior molar pregnancy. However, there is an increased risk for molar pregnancy in patients with a history of prior spontaneous abortions and infertility [4]. Beta-hCG are typically greater than > 100,000 mlU/mL signifying excessive trophoblastic growth, however a value < 100,000 mlU/mL does not exclude the diagnosis of molar pregnancy as partial moles tend not to produce as much beta-HCG [3].

These images, taken by point of care ultrasound, show a heterogenic mass with mixed echogenicities within the uterine cavity consistent with gestational trophoblastic disease or molar pregnancy. Obstetrics and Gynecology was consulted for definitive management. The patient was taken to the operating room for dilation and curettage and was discharged the following day.

Take-Home Points

  • Physical exam findings of an enlarged uterus inconsistent with gestational age, vaginal bleeding, and intractable nausea and vomiting should clue you into a possible molar pregnancy.
  • Point-of-care ultrasound is an invaluable tool when assessing vaginal bleeding and will often help the clinician in the management or diagnostic pathway.
  • Beta-hCG < 100,000 mlU/mL does not rule out molar pregnancy. Obtain a good history, perform a thorough physical exam, and pick up your ultrasound probe.

  • Soper, John T. “Gestational Trophoblastic Disease.” Obstetrics & Gynecology, vol. 137, no. 2, 2021, pp. 355–370., https://doi.org/10.1097/aog.0000000000004240.
  • Cline, David, et al. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide. McGraw-Hill Education, 2020.
  • Berkowitz, Ross S., and Donald P. Goldstein. “Molar Pregnancy.” New England Journal of Medicine, vol. 360, no. 16, 2009, pp. 1639–1645., https://doi.org/10.1056/nejmcp0900696.
  • Acaia, Barbara, et al. “Increased Frequency of Complete Hydatidiform Mole in Women with Repeated Abortion.” Gynecologic Oncology, vol. 31, no. 2, 1988, pp. 310–314., https://doi.org/10.1016/s0090-8258(88)80009-x.

By |2024-02-11T20:06:03-08:00Feb 12, 2024|Ob/Gyn, SAEM Clinical Images|
Go to Top